|
|
|
|
Radio frequency identification (RFID)-based unit-level tracking for prefilled syringes can help pharma manufacturers reduce risk and ease costly bottlenecks in the fill-finish process. By tagging individual syringes, manufacturers open new pathways for traceability and risk mitigation.
|
|
|
|
|
These frequently asked questions explore the research and design thinking behind the BD Neopak™ XtraFlow™ solution. Learn how its 8 mm needles are designed to improve the injection experience and deliver clinical benefits for chronic care patients.
|
|
|
|
|
An early feasibility clinical study of the BD Libertas™ Wearable Injector showed consistent functional performance across all injection sites. The device also earned broad acceptance from subjects spanning every demographic category tested.
|
|
|
|
|
High-viscosity biologics and large fill volumes are straining conventional prefillable syringe designs. BD Neopak's modular glass platform addresses drug-container compatibility, injection performance, and large-volume subcutaneous delivery.
|
|
|
|
|
|
|
A next‑generation injectable system uses shorter, thinner needles to reduce injection risk, lower force and time requirements, and improve comfort and usability for administering viscous formulations.
|
|
|
